Zynex reports fourth quarter and full year 2023 financial results

Fy 2023 revenue increased 17% to $184.3 million company announces additional $20 million stock repurchase plan englewood, colo. , feb. 29, 2024 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the fourth quarter and full year ended december 31, 2023 and its board of directors has approved an additional program to repurchase up to $20.0 million of the company's common stock.
ZYXI Ratings Summary
ZYXI Quant Ranking